INS and Hypoglycemia: Thus, the risk of nocturnal confirmed hypoglycemia was significantly lower in the twice-daily IDegAsp group (OR 0.52, 95% CI 0.42 to 0.65, I2 = 23.9%; Figure 4B) than that in the twice-daily conventional premixed insulin group.